TD Cowen analyst Charles Rhyee lowered the firm’s price target on Teladoc to $16 from $22 and keeps a Market Perform rating on the shares. The firm said while the company beat 4Q adjusted EBITDA and 2024 guide bracketed consensus, 4Q topline missed and 2024 and long-term outlook was disappointing.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on TDOC:
- Teladoc Inc. Earnings Update: Did it Beat Estimate Forecasts?
- Teladoc (NYSE:TDOC) Delivers Mixed Q4, Stock Drops On Downbeat Outlook
- Teladoc Health Reports Fourth Quarter and Full Year 2023 Results
- Options Volatility and Implied Earnings Moves Today, February 20, 2024
- Teladoc Health Provides Updated Start Time for Fourth Quarter 2023 Earnings Call on February 20, 2024
